These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25719300)

  • 1. Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection.
    Abd El Dayem SM; Battah AA; El Shehaby A; Abd Allah N
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):309-14. PubMed ID: 25719300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
    Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
    Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethyl L-arginine, nitric oxide and cardiovascular disease in adolescent type 1 diabetics.
    Abd El Dayem SM; Battah AA; El-Shehaby A; El Bohy Ael M
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):437-44. PubMed ID: 24468606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.
    Aguilera E; Serra-Planas E; Granada ML; Pellitero S; Reverter JL; Alonso N; Soldevila B; Mauricio D; Puig-Domingo M
    Cardiovasc Diabetol; 2015 Sep; 14():121. PubMed ID: 26382922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2.
    Żurawska-Płaksej E; Ługowska A; Hetmańczyk K; Knapik-Kordecka M; Adamiec R; Piwowar A
    Biomarkers; 2015 Feb; 20(1):52-7. PubMed ID: 25519006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum preptin concentrations in patients with diabetic nephropathy.
    Wang R; Xue A; Zheng W; Wang L; Yan F; Hu W; Lin J; He L
    J Investig Med; 2019 Oct; 67(7):1048-1052. PubMed ID: 31182468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
    Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
    Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
    Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
    J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients.
    Tatar E; Gungor O; Celtik A; Sisman AR; Yaprak M; Asci G; Ozkahya M; Toz H
    Ann Transplant; 2013 Mar; 18():95-100. PubMed ID: 23792508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YKL-40 in type 2 diabetic patients with different levels of albuminuria.
    Brix JM; Höllerl F; Koppensteiner R; Schernthaner G; Schernthaner GH
    Eur J Clin Invest; 2011 Jun; 41(6):589-96. PubMed ID: 21158852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients.
    Lee JH; Kim SS; Kim IJ; Song SH; Kim YK; In Kim J; Jeon YK; Kim BH; Kwak IS
    J Diabetes Complications; 2012; 26(4):308-12. PubMed ID: 22705282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL-40 levels are associated with type 2 diabetes mellitus in patients with obstructive sleep apnea syndrome.
    Sun L; Liu JY; Li LR
    Genet Mol Res; 2015 Aug; 14(3):8919-25. PubMed ID: 26345823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes.
    Thomsen SB; Gjesing AP; Rathcke CN; Ekstrøm CT; Eiberg H; Hansen T; Pedersen O; Vestergaard H
    PLoS One; 2015; 10(7):e0133672. PubMed ID: 26197239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YKL-40 levels are independently associated with albuminuria in type 2 diabetes.
    Røndbjerg AK; Omerovic E; Vestergaard H
    Cardiovasc Diabetol; 2011 Jun; 10():54. PubMed ID: 21696606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus.
    Sakamoto F; Katakami N; Kaneto H; Yasuda T; Takahara M; Miyashita K; Kuroda A; Matsuhisa M; Kosugi K; Shimomura I
    Endocr J; 2013; 60(1):73-9. PubMed ID: 22986489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serum YKL-40 level and dysglycemia in cystic fibrosis.
    Bouvet GF; Maignan M; Arslanian E; Coriati A; Rabasa-Lhoret R; Berthiaume Y
    Cytokine; 2015 Feb; 71(2):296-301. PubMed ID: 25497736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
    Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
    Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma YKL-40 levels are elevated in patients with chronic heart failure.
    Rathcke CN; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Lip GY; Faber J; Vestergaard H
    Scand Cardiovasc J; 2010 Apr; 44(2):92-9. PubMed ID: 19961288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings.
    Ahmed SF; Attia EA; Saad AA; Sharara M; Fawzy H; El Nahrery EM
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):682-8. PubMed ID: 25087779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.